By staff writers

August 14, 2018 -- Guerbet USA, the U.S. affiliate of contrast developer Guerbet, has formed a commercial partnership with radiation dose-tracking software developer Imalogix.

Guerbet will offer the artificial intelligence-based Imalogix platform, which features a self-learning neural network that enables organizations to understand and benchmark best practices for radiation dose management of diagnostic imaging and interventional procedures, according to the company. Using the deep-learning software recommendations, institutions can proactively change behavior down to the scanner, protocol, and operator level, Guerbet said.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking